Show simple item record

FieldValueLanguage
dc.contributor.authorWebster, Angela C
dc.contributor.authorCross, Nicholas B
dc.date.accessioned2020-05-19
dc.date.available2020-05-19
dc.date.issued2015-10-22
dc.identifier.citationWebster AC, Cross NB. When evidence doesn't generalise: the case of ACE-inhibition. The Lancet Diabetes & Endocrinology, 2016; 4(4): 290-2en
dc.identifier.urihttps://hdl.handle.net/2123/22320
dc.language.isoenen
dc.publisherElsevieren
dc.rightsOtheren
dc.titleWhen evidence doesn't generalise: the case of ACE inhibitionen
dc.typeArticleen
dc.identifier.doi10.1016/S2213-8587(15)00415-5
dc.type.pubtypePost-printen
dc.rights.otherThis is a pre-copyedited, author-produced version of an article accepted for publication in Lancet Diabetes and Endocrinology following peer review. The version of record [Webster AC, Cross NB. When evidence doesn't generalise: the case of ACE-inhibition. The Lancet Diabetes & Endocrinology, 2016; 4(4): 290-2] is available online at: https://www.thelancet.com/journals/landia/article/PIIS2213-8587(15)00415-5/fulltext [https://doi.org/10.1016/S2213-8587(15)00415-5].en
usyd.facultyFaculty of Medicine and Health, Sydney Medical Schoolen


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.